1900
H. Mitsudera, C.-J. Li / Tetrahedron Letters 52 (2011) 1898–1900
Yagupolskii, Y. L.; Tyrra, W.; Naumann, D.; Fischer, H. T. M.; Scherer, H. J.
Fluorine Chem. 2008, 129, 14.
4. (a) Li, Z.; Li, C.-J. J. Am. Chem. Soc. 2004, 126, 11810; (b) Li, Z.; Li, C.-J. J. Am. Chem.
Soc. 2005, 127, 6968; (c) Basle, O.; Li, C.-J. Green Chem. 2007, 9, 1047; (d) Li, C. J.
Acc. Chem. Res. 2009, 42, 335.
5. Basle, O.; Li, C.-J. Org. Lett. 2008, 10, 3661.
6. Baslé, O.; Li, C.-J. Chem. Commun. 2009, 4124.
7. Chu, L.; Qing, F.-L. Chem. Commun. 2010, 46, 6285.
8. Tsang, A. S.-K.; Todd, M. H. T. Tetrahedron Lett. 2009, 50, 1199.
9. Oishi, M.; Kondo, H.; Amii, H. Chem. Commun. 2009, 1909.
0.2 mmol) was dropped into the mixture over 5 min under argon at
room temperature. The resulting mixture was stirred at the same
temperature for 15 min. The resulting suspension was diluted with
hexane/ethyl acetate (3/1) solution and then saturated sodium
hydrogen carbonate aqueous solution was dropped into the reac-
tion mixture. After the organic layer was separated, the water layer
was extracted twice with hexane/ethyl acetate (3/1) solution. The
combined organic layer was washed twice with water and dried
with sodium sulfate. The resulting solution was filtered through
a short silica gel in a pipette eluting with hexane/ethyl acetate
(3/1). Solvent was evaporated and the residue was purified by flash
column chromatography on silica gel with hexane as eluent to give
the desired product.10
10. Characterization
of
unknown
compounds.
2-(3-Methoxyphenyl)-1-
(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline 2c: 1H NMR (300 MHz, CDCl3,
293 K, TMS): d ppm 7.34–7.19 (m, 5H), 6.59 (dd, J = 2.4 Hz, J = 8.1 Hz, 1H), 6.53
(t, J = 2.4 Hz, 1H), 6.42 (dd, J = 2.4 Hz, J = 8.1 Hz, 1H), 5.14 (q, J = 7.8 Hz, 1H),
3.82 (s, 3H), 3.83–3.75 (m, 1H), 3.55–3.47 (m, 1H), 3.07–3.02 (m, 2H). 19F NMR
(282 MHz, CDCl3): d ppm À71.5 (d, J = 7.9 Hz, 3F). 13C NMR (75 MHz, CDCl3,
293 K, TMS): d ppm 160.7, 150.7, 136.8, 130.0, 128.8 (t, J = 1.7 Hz), 128.7, 128.5,
127.9, 107.3 (d, J = 1.1 Hz), 103.5, 101.4, 60.7 (q, J = 26.5 Hz), 55.3, 43.6, 27.4 (d,
J = 1.1 Hz). HRMS ESI (m/z): [M+H]+ calcd for C17H17ONF3, 308.12568; found,
308.12536. 2-(4-Bromophenyl)-1-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline
2e: 1H NMR (300 MHz, CDCl3, 293 K, TMS): d ppm 7.38–7.23 (m, 6H), 6.83
(d, J = 9.0 Hz, 2H), 5.06 (q, J = 8.1 Hz, 1H), 3.80–3.73 (m, 1H), 3.48–3.40 (m, 1H),
3.09–3.01 (m, 2H). 19F NMR (282 MHz, CDCl3): d ppm À71.6 (d, J = 7.6 Hz, 3F).
13C NMR (75 MHz, CDCl3, 293 K, TMS): d ppm 148.3, 136.6, 132.0, 128.8 (d,
J = 4.4 Hz), 128.5, 126.5, 116.0, 111.2, 60.4 (q, J = 30.4 Hz), 43.7, 27.4. HRMS ESI
(m/z): [M+H]+ calcd for C16H14BrNF3, 356.02567; found, 356.02592. 2-(1-
Naphthyl)-1-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline 2h: 1H NMR
(300 MHz, CDCl3, 293 K, TMS): d ppm 8.35–8.31 (m, 1H), 7.89–7.86 (m, 1H),
7.63 (d, J = 8.1 Hz, 1H), 7.57–7.46 (m, 3H), 7.40–7.24 (m, 4H), 7.02 (br s, 1H),
4.99 (q, J = 8.4 Hz, 1H), 3.87 (br s, 1H), 3.44–3.40 (m, 1H), 2.82 (br s, 2H). 19F
NMR (282 MHz, CDCl3): d ppm À72.5 (br s, 3F). 13C NMR (75.4 MHz, CDCl3,
293 K, TMS): d ppm 148.3, 137.3, 134.9, 129.3, 128.7 (q, J = 2.2 Hz), 128.4,
126.3, 126.2, 126.1, 125.7, 125.0, 123.8, 119.8, 113.1, 62.3(q, J = 28.7 Hz), 47.2,
26.2. HRMS ESI (m/z): [M+H]+ calcd for C20H17NF3, 328.13076; found,
328.13126. 2-(2-Pyridyl)-1-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline 2i:
1H NMR (300 MHz, CDCl3, 293 K, TMS): d ppm 8.23 (d, J = 3.6 Hz, 1H), 7.52 (t,
J = 6.6 Hz, 1H), 7.40 (d, J = 7.2 Hz, 1H), 7.33–7.22 (m, 3H), 6.71 (d, J = 7.8 Hz,
1H), 6.67 (t, J = 5.1 Hz, 1H), 6.46 (q, J = 8.4 Hz, 1H), 3.87–3.81 (m, 1H), 3.78–3.70
(m, 1H), 3.18–3.09 (m, 1H), 5.05–2.56 (m, 1H). 19F NMR (282 MHz, CDCl3): d
ppm À71.6 (d, J = 8.8 Hz, 3F). 13C NMR (75.4 MHz, CDCl3, 293 K, TMS): d ppm
157.7, 147.6, 137.8, 136.6, 129.2, 129.1, 129.0, 128.6, 128.5, 127.8, 126.4,
124.0, 113.8, 106.5, 54.6 (q, J = 30.4 Hz), 41.5, 27.5 (d, J = 1.1 Hz). HRMS ESI
(m/z): [M+H]+ calcd for C15H14N2F3, 279.11036; found, 279.10998. 2-(2-
Pyridylmethyl)-1-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline 2k: 1H NMR
(300 MHz, CDCl3, 293 K, TMS): d ppm 8.52 (d, J = 4.5 Hz, 1H), 7.74–7.68 (m,
1H), 7.59 (d, J = 7.8 Hz, 1H), 7.31–7.16 (m, 5H), 4.36 (q, J = 8.1 Hz, 1H), 4.14 (s,
2H), 3.31–3.23 (m, 1H), 2.87–2.85 (m, 2H), 2.79–2.73 (m, 1H). 19F NMR
(282 MHz, CDCl3): d ppm À73.2 (s, 3F). 13C NMR (75.4 MHz, CDCl3, 293 K,
TMS): d ppm 159.1, 148.9, 137.3, 136.9, 129.5 (d, J = 2.2 Hz), 128.6, 128.3,
128.2, 126.1, 122.6, 122.3, 62.8(d, J = 27.6 Hz), 62.5, 46.3, 27.3. HRMS ESI (m/z):
[M+H]+ calcd for C16H16N2F3, 293.12601; found, 293.12555.
Acknowledgments
We are grateful to the Canada Research Chair (Tier I) foundation
(to C.-J. Li), NSERC, FRQNT and McGill University for support of our
research.
References and notes
1. (a) Shimizu, M.; Hiyama, T. Angew. Chem., Int. Ed. 2005, 44, 214; (b) Muller, K.;
Faeh, C.; Diederich, C. Science 2007, 317, 1881; (c) Watson, D. A.; Su, M.;
Teverovskiy, G.; Zhang, Y.; Garcia-Fortanet, J.; Kinzel, T.; Buchwald, S. L. Science
2009, 325, 1661; (d) Sani, M.; Volonterio, A.; Zanda, M. J. Med. Chem. 2007, 2,
1693; (e) Leger, S.; Bayly, C. I.; Black, W. C.; Desmarais, S.; Falgueyret, J.-P.;
Masse, F.; Percival, M. D.; Truchon, J.-F. Bioorg. Med. Chem. Lett. 2007, 17, 4328;
(f) Grunewald, G. L.; Caldwell, T. M.; Li, Q.; Criscione, K. R. J. Med. Chem. 1999,
42, 3315; (g) Faraci, W. S.; Walsh, C. T. Biochemistry 1989, 28, 431.
2. (a) Singh, R. P.; Shreeve, J. M. Tetrahedron 2000, 56, 7613; (b) Prakash, G. K. S.;
Mandel, M. J. Fluorine Chem. 2001, 112, 123; (c) Ruppert, L.; Schlich, K.; Volbach,
W. Tetrahedron Lett. 1984, 25, 2195; (c) Beckers, H.; Burger, P.; Bursch, P.;
Ruppert, I. J. Organomet. Chem. 1986, 316, 41; (d) Prakash, G. K. S.;
Krishnamurti, R.; Olah, G. A. J. Am. Chem. Soc. 1989, 111, 393; (e) Kotun, S. P.;
Anderson, J. D. O.; DesMarteau, D. D. J. Org. Chem. 1992, 57, 1124.
3. (a) Felix, C. P.; Khatimi, N. A.; Laurent, J. Tetrahedron Lett. 1994, 35, 3303; (b)
Nelson, D. W.; Easley, R. A.; Pintea, B. N. V. Tetrahedron Lett. 1999, 40, 25; (c)
Nelson, D. W.; Owen, J.; Hiraldo, D. J. Org. Chem. 2001, 66, 2572; (d) Petrov, V. A.
Tetrahedron Lett. 2000, 41, 6959; (e) Prakash, G. K. S.; Mandeal, M.; Olah, G. A.
Angew. Chem., Int. Ed. 2001, 40, 589; (f) Prakash, G. K. S.; Mandeal, M.; Olah, G.
A. Org. Lett. 2001, 3, 2847; (g) Prakash, G. K. S.; Mandeal, M. J. Am. Chem. Soc.
2002, 124, 6538; (h) Kawano, Y.; Fujisawa, H.; Mukaiyama, T. Chem. Lett. 2005,
34, 422; (i) Mizuta, S.; Shibata, N.; Sato, T.; Fujimoto, H.; Nakamura, S.; Toru, T.
Synlett 2006, 267; (h) Kiriji, N. V.; Babadzhanova, L. A.; Movchun, V. N.;